Cite

HARVARD Citation

    Omata, M. et al. (2014). Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open‐label, phase 3 trial. Journal of viral hepatitis. 21 (11), pp. 762-768. [Online]. 
  
Back to record